Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia
Psychiatry and Clinical Neurosciences · 2026-08 · 80 (8) · 703-704
DOI: 10.1111/pcn.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, online erschienen am 28.05.2026. Verfasst von Yuki Matsuda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Development and Education of Clinical Research, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Tardive Dyskinesia, Cholinergic Antagonists, Vesicular Monoamine Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This article relates to Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Development and Education of Clinical Research, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Centre for Translational Research, Fujita Health University, Toyoake, Aichi, Japan.
Zitieren
APA
Matsuda, Y., & Suzuki, Y. (2026). Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia. Psychiatry and Clinical Neurosciences, 80(8), 703-704. https://doi.org/10.1111/pcn.70089
Vancouver
Matsuda Y, Suzuki Y. Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia. Psychiatry and Clinical Neurosciences. 2026;80(8):703-704. doi:10.1111/pcn.70089
BibTeX
@article{Matsuda2026,
author = {Matsuda, Yuki and Suzuki, Yuta},
title = {Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia},
journal = {Psychiatry and Clinical Neurosciences},
year = {2026},
volume = {80},
number = {8},
pages = {703--704},
doi = {10.1111/pcn.70089}
}
EUVIMED